Kevin Robert Lind

CIK 1677036 · President and CEO · last filed 2026-06-04

Kevin Robert Lind is a President and CEO who has filed 18 SEC Form 4 insider transactions across 3 companies since 2016. The most recent filing, for AVTX, was dated Jun 4, 2026. Across all open-market trades the lifetime net is −$247.5K, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

18

Lifetime Open-Market Net

-$247.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AVTX Director $14.76 $0 4 2026-06-04
Longboard Pharmaceuticals, Inc. (LBPH) Delisted President and CEO 0 $59.98 $0 $0 7 2024-12-02
ARENA PHARMACEUTICALS INC (ARNA) Delisted Executive VP and CFO 7,957 $99.99 $795.6K -$247.5K 7 2020-03-03

Recent Filings

18 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-06-04 AVTX Grant (A) $0 EDGAR
2026-04-01 AVTX Grant (A) $0 EDGAR
2026-01-05 AVTX Grant (A) $0 EDGAR
2025-10-02 AVTX Grant (A) $0 EDGAR
2024-12-02 Longboard Pharmaceuticals, Inc. (LBPH) Delisted Mixed −363,740 -$21.82M EDGAR
2024-11-13 Longboard Pharmaceuticals, Inc. (LBPH) Delisted Mixed −67,192 $40.0K EDGAR
2024-10-29 Longboard Pharmaceuticals, Inc. (LBPH) Delisted Grant (A) $0 EDGAR
2024-08-13 Longboard Pharmaceuticals, Inc. (LBPH) Delisted Exer (M) +82,482 $260.0K EDGAR
2024-02-09 Longboard Pharmaceuticals, Inc. (LBPH) Delisted Grant (A) $0 EDGAR
2023-02-10 Longboard Pharmaceuticals, Inc. (LBPH) Delisted Grant (A) $0 EDGAR
Showing 110 of 18
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.